Zaloguj się

Gotowe bibliografie tematyczne / Biotechnology / Artykuły w czasopismach

Artykuły w czasopismach na temat „Biotechnology”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Biotechnology.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Biotechnology”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Yaseen, Arshed H., Halah M. H. Al-Hasani i Umer Abdullah Ahmed Alelyan. "Biotechnology for medical diagnosis". Drug and Pharmaceutical Science Archives 02, nr 01 (2022): 01–05. http://dx.doi.org/10.47587/dpsa.2022.2101.

Pełny tekst źródła

Streszczenie:

Biotechnology is broadly defined as, “using organisms or their products for commercial purposes” encompasses a wide range. Since the beginning of time, people have used (traditional) biotechnology. Wheat, brew alcohol, and breed food crops and domestic animals have all been made using this grain. Molecular biology’s most recent breakthroughs, on the other hand, have given new life to biotechnology’s relevance and potential. Biotechnology has become a hot topic among the general public. There’s a good chance that modern biotechnology will have a big impact on the environment. Small-molecule (chemical) medications produced by well-known pharmaceutical companies have traditionally accounted for the vast majority of human illness treatments. The current article discussed.

Style APA, Harvard, Vancouver, ISO itp.

2

Adeyinka, Olawale Samuel, Oghenerobor Benjamin Akpor i Abimbola Pius Okiki. "Untapped potentials of Agricultural Biotechnology in Nigeria". Journal of Bioscience and Biotechnology Discovery 6, nr 4 (30.10.2021): 33–37. http://dx.doi.org/10.31248/jbbd2021.152.

Pełny tekst źródła

Streszczenie:

The field of biotechnology has witnessed a significant achievement over the past decades. Although biotechnology always sparked a great deal of ethical criticism, the advancement has continued to offer an opportunity to address several social and economic challenges. The potentials of biotechnology remain underexploited in several fields in Nigeria. This review highlighted some untapped biotechnologies that represent an ample scope of biotechnology application used for the genetic improvement of plant and animal populations, conservation of genetic resources, and diagnosis of plant and animal diseases. Factors such as insufficient of funds to procure facilities, inadequate power supply, lack of sufficient trained manpower, lack of political will to support biotechnology has been limiting biotechnology's potentials in Nigeria. Therefore, it was recommended that attention should be given to biotechnology research and development to complement existing expertise in the national biotechnology sector towards maximizing its potentials.

Style APA, Harvard, Vancouver, ISO itp.

3

Boulay, Jean-Louis, i Sylvie Miot. "Chemical biotechnology Pharmaceutical biotechnology". Current Opinion in Biotechnology 11, nr 6 (grudzień 2000): 515. http://dx.doi.org/10.1016/s0958-1669(00)00138-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Boulay, Jean-Louis. "Pharmaceutical biotechnology: Chemical biotechnology". Current Opinion in Biotechnology 10, nr 6 (grudzień 1999): 523–24. http://dx.doi.org/10.1016/s0958-1669(99)00022-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Verjan García, Noel. "Biotechnology, powerful tools for research and development". Orinoquia 13, nr 1 (1.01.2009): 2. http://dx.doi.org/10.22579/20112629.217.

Pełny tekst źródła

Streszczenie:

ABSTRACT: The concept of biotechnology has been in the human mind since very ancient times, when the first human beings discovered the production of wine by fermenting fruit juices, the brewing beer industry, and the conversion of milk into cheese or yogurt. However, as these basic processes have going through a wide range of developments to supply specific requirements, biotechnology has evolved and some of its most dramatic advances were observed during in the last 30-years. Modern biotechnology begins with the ability to transfer a specific gene from one organism to another by using a set of genetic engineering techniques, thus recombinant DNA technology sparked an era o biotech revolution. This major achievement, together with the maintenance and growth of genetically uniform plant-and animal cell cultures increased dramatically the spectrum of biotechnology’s applications in disease prevention, treatment and quality of life.

Style APA, Harvard, Vancouver, ISO itp.

6

Zamora-González, Edgar Oswaldo, Angel Herráez, Paula Daniela Gutiérrez-Muñoz, Olivia Torres-Bugarín, María Valentina Toral-Murillo, Benjamín Gómez-Díaz, Cecilia Adriana Calderón-Reyes i in. "Implementation of Biotechnology Applied to Medicine Course Using Virtual Laboratories: Perceptions and Attitudes of Students". Education Sciences 14, nr 2 (2.02.2024): 157. http://dx.doi.org/10.3390/educsci14020157.

Pełny tekst źródła

Streszczenie:

The rapid evolution of biotechnology across various sectors, including agriculture, industry, and medicine, has profoundly transformed our comprehension of the world. Virtual laboratories (VLs) provide an immersive learning experience that can enhance future generations’ understanding of biotechnology’s medical applications. This study investigated the impact of incorporating VLs into a short course on biotechnology applied to medicine on the attitudes and perceptions of third-year medical students (n = 210). A validated questionnaire was employed to assess their perspectives, attitudes, and experience with virtual laboratory platforms before and after the course. The findings revealed a significant positive change in 7/38 questionnaire items (p < 0.05), indicating that the VL experience modified perceptions about biotechnology. This study emphasizes the importance of exploring innovative teaching methods for biotechnology and highlights the advantages of VL in educating future physicians. The primary concerns of the students were the misuse of personal genetic information and biotechnological applications involving animal modification. Overall, the students had a favorable experience using the virtual laboratory platforms. These findings collectively suggest that VL can positively influence perceptions and attitudes toward biotechnology among healthcare professionals.

Style APA, Harvard, Vancouver, ISO itp.

7

Gábor, Miklós Gábor, i Ubul Pál Kralovánszky. "The father of the term ‘biotechnology’ was Hungarian: The forgotten works of Károly Ereky". Acta Agraria Debreceniensis, nr 17 (14.09.2005): 107–10. http://dx.doi.org/10.34101/actaagrar/17/3279.

Pełny tekst źródła

Streszczenie:

In the Nature, Robert Bud gave an account of the fact that the generator of the concept "biotechnology" was the Hungarian Karl Ereky who, in his book published in Berlin in 1919 entitled "Biotechnologie der Fleisch-, Fett- und Milcherzeugung im landwirtschaftlichen Grossbetriebe" ("Biotechnology of Meat, Fat and Milk Production in a Large-Scale Agricultural Farm"), disclosed his observations and new views in that regard. Later on, Ereky's two essays, published in German language again, and other contemporary German sources have been processed which have confirmed the assumption whereas – in scientific terms – the further first applications of the expression "biotechnology" can be attributed to Ereky's works. Recently, we have explored and found biographical sources and documents which had been published by Ereky, which, however, have already been forgotten, by dint of which the story of origin of the first concept "biotechnology" can as well be clarified in a factual manner.

Style APA, Harvard, Vancouver, ISO itp.

8

Birkinshaw, Julian, Ivanka Visnjic i Simon Best. "Responding to a Potentially Disruptive Technology: How Big Pharma Embraced Biotechnology". California Management Review 60, nr 4 (5.06.2018): 74–100. http://dx.doi.org/10.1177/0008125618778852.

Pełny tekst źródła

Streszczenie:

How do incumbent firms respond over time to a potentially disruptive technology? This article documents the strategies of 12 large pharmaceutical firms over 25 years as they addressed the opportunity/threat of biotechnology. All showed awareness of biotechnology’s potential, but their response profiles varied dramatically in terms of timing (early/late) and focus (external/internal). Late movers mostly made large acquisitions to “catch up,” but early movers maintained their lead in terms of biotechnology-based drug sales and profitability, and those with a more “open” response profile performed better. This response involves a three-step process: building awareness (sensing), building capability (responding), and building commitment (scaling).

Style APA, Harvard, Vancouver, ISO itp.

9

Sapozhnikova, Alla Sapozhnikova, i Elena Pekhtasheva. "Collagen Applications in Biotechnology". Indian Journal of Applied Research 4, nr 5 (1.10.2011): 625–27. http://dx.doi.org/10.15373/2249555x/may2014/197.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Silpa, S. "Nanotechnology-Present Revolutionary Biotechnology". International Journal of Pharma Research and Health Sciences 4, nr 4 (2016): 1261–67. http://dx.doi.org/10.21276/ijprhs.2016.04.03.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Klyuchko, O. M. "CLUSTER ANALYSIS IN BIOTECHNOLOGY". Biotechnologia Acta 10, nr 5 (październik 2017): 5–18. http://dx.doi.org/10.15407/biotech10.05.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

TAKATSUJI, Masamoto. "Biotechnology." Journal of the Japan Society for Precision Engineering 54, nr 1 (1988): 51–52. http://dx.doi.org/10.2493/jjspe.54.51.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Santiago Vispo, Nelson. "Biotechnology". Bionatura 1, nr 1 (15.01.2016): 3. http://dx.doi.org/10.21931/rb/2016.01.01.1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Wickelgren, Ingrid. "Biotechnology". Science News 135, nr 19 (13.05.1989): 300. http://dx.doi.org/10.2307/3973298.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Sun, Marjorie. "Biotechnology". Science 228, nr 4705 (14.06.1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294.b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Sun, Marjorie. "Biotechnology". Science 228, nr 4705 (14.06.1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294-b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Mote, Patricia. "Biotechnology". American Biology Teacher 70, nr 3 (1.03.2008): 173–74. http://dx.doi.org/10.2307/30163233.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

KAMAKURA, Takashi, Toshihiro NAGAMINE i Hideo OHKAWA. "BIOTECHNOLOGY". Journal of Pesticide Science 19, Special (1994): S309—S313. http://dx.doi.org/10.1584/jpestics.19.special_s309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Bennett, Dawn D., i Julie Ann Miller. "Biotechnology". Science News 127, nr 21 (25.05.1985): 329. http://dx.doi.org/10.2307/3969682.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Morohoshi, Noriyuki. "Biotechnology." JAPAN TAPPI JOURNAL 41, nr 10 (1987): 983–91. http://dx.doi.org/10.2524/jtappij.41.983.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Evens, Ronald P., i Mark Witcher. "Biotechnology". Therapeutic Drug Monitoring 15, nr 6 (grudzień 1993): 514–20. http://dx.doi.org/10.1097/00007691-199312000-00011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

HARLANDER, SUSAN K. "Biotechnology". Nutrition Today 22, nr 4 (lipiec 1987): 21–29. http://dx.doi.org/10.1097/00017285-198708000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Cole-Turner, Ronald. "Biotechnology". Theology Today 59, nr 1 (kwiecień 2002): 39–54. http://dx.doi.org/10.1177/004057360205900104.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem i Steve Projan. "Biotechnology". Current Opinion in Biotechnology 11, nr 2 (kwiecień 2000): 109–14. http://dx.doi.org/10.1016/s0958-1669(00)00067-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz i Steve Projan. "Biotechnology". Current Opinion in Biotechnology 11, nr 3 (czerwiec 2000): 219–25. http://dx.doi.org/10.1016/s0958-1669(00)00101-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Cass, Tony, Jim Dunwell, Andrew J. Dauglis, Thomas A. Kost, Patrick Condreay i Jeroen Hugenholtz. "Biotechnology". Current Opinion in Biotechnology 11, nr 4 (sierpień 2000): 309–13. http://dx.doi.org/10.1016/s0958-1669(00)00103-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz i Michiel Kleerebezem. "Biotechnology". Current Opinion in Biotechnology 12, nr 2 (kwiecień 2001): 113–19. http://dx.doi.org/10.1016/s0958-1669(00)00182-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Dunwell, Jim, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz i Michiel Kleerebezem. "Biotechnology". Current Opinion in Biotechnology 12, nr 3 (czerwiec 2001): 221–26. http://dx.doi.org/10.1016/s0958-1669(00)00203-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz, Nicholas J. Turner i Robert E. Speight. "Biotechnology". Current Opinion in Biotechnology 12, nr 4 (sierpień 2001): 321–28. http://dx.doi.org/10.1016/s0958-1669(00)00221-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steven Projan i in. "Biotechnology". Current Opinion in Biotechnology 13, nr 1 (luty 2002): 1–8. http://dx.doi.org/10.1016/s0958-1669(02)00275-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Dunwell, Jim, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, Nicholas J. Turner i Robert E. Speight. "Biotechnology". Current Opinion in Biotechnology 13, nr 2 (kwiecień 2002): 77–81. http://dx.doi.org/10.1016/s0958-1669(02)00289-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Halliwell, Catherine, Tony Cass, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay i in. "Biotechnology". Current Opinion in Biotechnology 13, nr 4 (sierpień 2002): 279–86. http://dx.doi.org/10.1016/s0958-1669(02)00342-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Halliwell, Catherine, Tony Cass, Jim Dunwell, LawrenceP Wackett, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, NicholasJ Turner i RobertE Speight. "Biotechnology". Current Opinion in Biotechnology 13, nr 5 (październik 2002): 407–11. http://dx.doi.org/10.1016/s0958-1669(02)00371-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem i Andrew J. Daugulis. "Biotechnology". Current Opinion in Biotechnology 10, nr 6 (grudzień 1999): 517–22. http://dx.doi.org/10.1016/s0958-1669(99)00021-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

CASS, T., J. DUNWELL, L. WHACKETT, G. GILARDI, T. KOST, P. CONDREAY i D. POMPLIANO. "Biotechnology". Current Opinion in Biotechnology 10, nr 2 (1.04.1999): 105–11. http://dx.doi.org/10.1016/s0958-1669(99)80018-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Hecht, Hans-Jürgen, i Dieter Strack. "Biotechnology". Phytochemistry 53, nr 5 (marzec 2000): 620. http://dx.doi.org/10.1016/s0031-9422(99)00588-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Varela, Justo Corti. "Biotechnology". European Journal of Risk Regulation 1, nr 1 (marzec 2010): 63–71. http://dx.doi.org/10.1017/s1867299x00000076.

Pełny tekst źródła

Streszczenie:

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

Style APA, Harvard, Vancouver, ISO itp.

38

Mereu, Claudio. "Biotechnology". European Journal of Risk Regulation 2, nr 4 (grudzień 2011): 553–56. http://dx.doi.org/10.1017/s1867299x00001598.

Pełny tekst źródła

Streszczenie:

Regulation n. 1107/2009 of the European Parliament and Council of 21 October 2009 concerning the placing of plant protection products on the market entered into force on 14 December 2009 and applies as of 14 June 2011, subject to some transitional measures set out in Article 80. It shall replace gradually the current legislation on plant protection products which is laid down in Council Directive 91/414/EEC and related implementing Regulations.Broadly speaking, the harmonized authorization system for active substances used in plant protection products, as originally set out in Directive 91/414/ EEC, is maintained. Indeed, the placing on the market of plant protection products is still subject to a two-steps process whereby active substances are approved at the EU-level (with the inclusion into a “positive list” – Annex I to the new Regulation) while formulated products are authorised at the national level based on “Uniform Principles” laid down in a new implementing Regulation 546/2011. However, the criteria underlying each of these two steps have changed remarkably.

Style APA, Harvard, Vancouver, ISO itp.

39

GREGER, J. L. "Biotechnology". Journal of the American Dietetic Association 100, nr 11 (listopad 2000): 1306–8. http://dx.doi.org/10.1016/s0002-8223(00)00370-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Leigh, Ron. "Biotechnology". Transactions of the Institute of Measurement and Control 19, nr 5 (grudzień 1997): 222. http://dx.doi.org/10.1177/014233129701900501.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Bruhn, Christine M. "BIOTECHNOLOGY". Nutrition Today 33, nr 1 (styczeń 1998): 13–18. http://dx.doi.org/10.1097/00017285-199801000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Lesch, William C., Cheryl J. Wachenheim i Bard S. Stillerad. "Biotechnology". Health Marketing Quarterly 22, nr 3 (1.01.2005): 59–81. http://dx.doi.org/10.1300/j026v22n03_05.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Byford, G. H. "Biotechnology". Journal of Biomedical Engineering 10, nr 1 (styczeń 1988): 3. http://dx.doi.org/10.1016/0141-5425(88)90019-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Abrams, Fredrick R. "Biotechnology". JAMA 289, nr 4 (22.01.2003): 488. http://dx.doi.org/10.1001/jama.289.4.488.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

White, William E. "Biotechnology". Applied Biochemistry and Biotechnology 15, nr 1 (czerwiec 1987): 81–83. http://dx.doi.org/10.1007/bf02798507.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Oniang'o, Ruth. "Biotechnology". African Journal of Food, Agriculture, Nutrition and Development 9, nr 4 (25.06.2009): 1. http://dx.doi.org/10.18697/ajfand.25.ed018.

Pełny tekst źródła

Streszczenie:

The current issue of AJFAND covers a wide range of issues and also has a commentary on biotechnology by a world renown bio-philosopher, Prof Paul Thompson of the University of Toronto. Prof Thompson and I have known each other for close to a decade and have exchanged views on this issue to great length. Further, I have made arrangements for him to give lectures at the University of Nairobi and at Masinde Muliro University in Kenya.

Style APA, Harvard, Vancouver, ISO itp.

47

Oniang'o, Ruth. "Biotechnology". African Journal of Food, Agriculture, Nutrition and Development 6, nr 1 (29.04.2006): 1. http://dx.doi.org/10.18697/ajfand.10.ed003.

Pełny tekst źródła

Streszczenie:

As we go to press, the World Trade Organization (WTO) has ruled in favor of a case that was pending before it against the EU for enforcing rules that were unfavorable to genetically modified foods or associated products from the United States of America .

Style APA, Harvard, Vancouver, ISO itp.

48

Miot, Sylvie, i Jean-Louis Boulay. "Pharmaceutical biotechnology, Chemical biotechnology: Web alert". Current Opinion in Biotechnology 13, nr 6 (grudzień 2002): 531–32. http://dx.doi.org/10.1016/s0958-1669(02)00383-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Redaktion, TATuP. "Biotechnology ethics and public perceptions of biotechnology". TATuP - Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis 9, nr 4 (1.12.2000): 149. http://dx.doi.org/10.14512/tatup.9.4.149.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Friedman, Yali. "For success in biotechnology, look beyond biotechnology". Journal of Commercial Biotechnology 16, nr 4 (październik 2010): 279–80. http://dx.doi.org/10.1057/jcb.2010.16.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!